Purpose A prospective, multicentre, observational study was undertaken to assess Tisseel ® Wbrin sealant for atraumatic mesh Wxation in inguinal hernia repair throughout France. Methods Surgeons recorded data on patients undergoing tension-free inguinal hernioplasty with mesh Wxation with Tisseel ® , regardless of the hernioplasty technique used. Assessments were made at 2 days and 1 month after surgery. Data on local complications, operation times and ease of product use were collected. Results In total, 1,201 patients were recruited (90% men, mean age 57 years), among which 526 procedures were performed using open techniques and 675 using laparoscopic repairs. Local complications occurred in 4.7% of patients: 3.0% haematoma, 1.4% seroma, 0.3% recurrence. The mean visual analogue scale (VAS)-rated pain scores were 3.2 pre-operatively, 2.3 immediately after surgery and 1.8 at 1 month. Surgeons rated the product as very easy to use.
Introduction
Inguinal hernia repair is the most frequently performed procedure in general surgery [1] . Over the last few years, the placement of a prosthetic mesh in front of the hernia oriWce has become an increasingly popular strategy to prevent recurrence. Several techniques exist that require permanent Wxation of the prosthesis to the abdominal wall, usually using tissue-penetrating devices like staples or sutures. However, such techniques can cause post-operative bleeding as well as pain due to nerve compression [2, 3] . In particular, most reports of chronic pain encountered after tension-free groin hernia repair are related to the use of these tissue-penetrating devices [3] [4] [5] .
The recognised problem of complications associated with permanent mesh Wxation methods in groin hernioplasty prompted the search for other Wxation techniques. Tisseel ®1 Wbrin sealant (Baxter Healthcare, DeerWeld, Illinois, USA) has been proposed as an alternative, atraumatic method for mesh Wxation based on its eVective, proven adhesive properties, as well as its potential additional wound-healing properties [6] [7] [8] .
Tisseel ® is a biodegradable, biological preparation combining highly concentrated, human plasma-derived Wbrinogen (75-115 mg/mL) and thrombin (500 IU/mL). The mixing of these components in the presence of calcium chloride leads to the development of a three-dimensional matrix of polymerised Wbrin Wbres in a process mimicking the last step of biological coagulation. Fibrin sealant can, therefore, be used as an adjuvant to haemostasis in a variety of surgical applications [9, 10] .
In 1997, Chevrel and Rath Wrst proposed Wbrin sealant as an alternate means of mesh Wxation in hernia repair, with the aim of reducing the rate of hernia recurrence [11] . Canonico et al. [9] later reported the beneWts of Wbrin sealant in reducing bleeding complications following hernia repair in patients with impaired coagulation. Katkhouda et al. [12] have since employed a pig model using a total extraperitoneal (TEP) technique to evaluate the tensile strength of mesh Wxation 12 days after the use of Tisseel ® , demonstrating equal strength to staples. The results of these studies have encouraged surgeons to use Wbrin sealant in daily practice as an atraumatic alternative to mechanical mesh Wxation.
In France, an estimated 87,500 tension-free hernioplasty procedures were performed in 2000 [13] . In order to assess the feasibility of a new technique of mesh Wxation, we set up an open, multicentre, observational study inviting surgeons across France to report their cases of groin hernia repair involving the Wxation of prosthetic meshes with Tisseel ® . It was intended that this registry of data would represent real-world surgical practice in France at the time of introduction of a surgical sealant, in the absence of data from large randomised controlled trials. Here, we report data from this study focusing on the rate of recurrence, post-operative pain and complications related to haemostasis, i.e. haematoma and seroma following hernia surgery with Tisseel ® as a means of mesh Wxation.
Materials and methods

Design
This prospective, multicentre, longitudinal study was initiated in 2003 by Baxter Healthcare under the guidance of a scientiWc co-ordinator (BD). An independent clinical research organisation was employed to monitor the study and analyse the data collected. French general surgeons performing at least 100 hernioplasty procedures per year, who were already using Wbrin sealant for mesh Wxation, were targeted for recruitment. This included surgeons from both private and public healthcare sectors.
Surgeons were asked to record data on adult patients who were scheduled to undergo tension-free hernioplasty, either by the open or laparoscopic approach, with Tisseel ® for mesh Wxation. No other criteria were stipulated by the study protocol other than that Tisseel ® was to be used within its approved indication. Coagulation disorders were not excluded.
The primary outcome of interest in this study of Wbrin sealant in hernia repair relates to bleeding complications, [3] indicate that the combined incidence of haematoma and seroma (excluding bruising) following either method of hernioplasty is approximately 14%. Based on this value, we estimated that we needed to enrol 1,333 cases to demonstrate a 25% reduction in bleeding complications, given a power level of 80% and a 5% two-sided signiWcance level. Other patient-centred outcome measures studied included recurrence, pain, infections and miscellaneous complications. Rigid deWnitions of each outcome were not provided, as this study was intended to reXect current practice, so classiWcations were left to the discretion of individual investigators.
Fifty surgeons were targeted for recruitment and each was asked to provide data on 30 cases in order to achieve the target of 1,333 patients, allowing for around 10% dropout.
Assessments
Approximately 2 weeks prior to surgery, surgeons completed a questionnaire with each patient to collect the following data: demography, hernia risk factors (prostatism, smoking, chronic constipation, chronic obstructive pulmonary disease), type of hernia, haemostasis parameters (prothrombin time, bleeding time, activated partial thromboplastin time), pain assessment (visual analogue scale [VAS] , where 0 = no pain and 10 = unbearable pain) and the use of analgesic treatments.
On the day of surgery, surgeons recorded the type of anaesthesia, surgical technique, mesh, means of Wxation, and duration of operation. They were also asked to complete a VAS-graded convenience score to describe Tisseel ® 's ease of use (where 0 = very easy and 10 = very diYcult). Surgeons were briefed to assess and report any post-operative complications occurring during the Wrst 48 h following surgery.
At the one-month follow-up visit, surgeons examined the patients for evidence of recurrence, including careful questioning to evaluate the level of any post-operative pain relative to pre-operative symptoms. Ultrasound imaging was undertaken at the discretion of the surgeon if it was thought to be necessary to conWrm recurrence. The duration of sick leave (in non-retired patients) was assessed. Surgeons also completed two additional questionnaires where appropriate: one when sutures had been used in association with Wbrin sealant to Wx the mesh and the other to describe the previous surgical technique that was used in case of initial recurrent hernia.
Statistical analysis
Descriptive statistics were performed on all of the parameters studied.
Ethical considerations
This study was run in accordance with the principles outlined in the Helsinki Declaration of 1964 and its subsequent amendments and in keeping with the Good Clinical Practice Guide (1988 version) and article L4113-6 of the Public Health Law of France. According to article 78-17 of French law on the freedom of access to computerised data of 06/ 01/78, the study protocol was approved by the French Advisory Board for the Treatment of Information Related to Research in the Health Sector and the French National Computer Council.
According to article L4113-6 of the Public Health Safety Law, the sponsor submitted the protocol and related documents to the National Medical Council (CNOM), who forwarded a favourable opinion on 27 March 2003.
Each patient was provided with an informed consent form by the operating surgeon.
Results
Collection of data
Forty-Wve surgeons from 42 public and private institutions of varying sizes completed study questionnaires on 1,201 patients within the allocated recruitment period of 1 year. In addition, 51 'associated sutures' and 29 'initial recurrent hernia' questionnaires were completed.
Pre-operative assessment Of the 1,201 patients, 90% were male and 47% were sedentary workers or retired. The mean age was 57 years, with a mean height of 1.72 m and mean body weight of 73.8 kg. A total of 38% of patients had at least one hernia risk factor (among them, 39% of patients smoked and 24% had prostatism). In the vast majority of cases, hernias were inguinal (99%) and primary (93%); 79% of hernias were unilateral. The mean pre-operative VAS pain rating was 3.2, indicating moderate pain (Table 1) .
Surgical technique
General anaesthesia was performed in 84% of the cases. The techniques used (Table 2) [3] .
In total, 23 diVerent brands of mesh were used; the most frequently used mesh was the composite Parietex (24%). Surgeons used sutures or staples in addition to Tisseel ® in 28% of patients, mainly (in 53% of cases) during Lichtenstein repair to Wx the prosthesis to the pubic angle or to reduce the hernia oriWce in direct hernia. Fixations were located on the pubis or on Cooper's ligament, generally with one suture/staple as per standard practice. The other reason cited for the use of sutures in addition to Tisseel ® was in order to reduce the size of the inguinal oriWce, and not for mesh Wxation to the abdominal wall.
The amount of Wbrin glue used was 1 mL in 0.4% of cases, 2 mL in 74.6% of cases and 5 mL in 25% of cases (mostly for bilateral hernia). Application devices were adapted to each kind of surgery (application needle or spray for the open techniques, soft or rigid dual-lumen catheters for laparoscopic techniques). Regardless of the application device used, surgeons found that Tisseel ® was easy to apply, with a mean VAS-graded convenience score of 1.6.
Short-term follow-up
Assessed 24-48 h after surgery, patients' mean VASgraded pain score was 2.3, indicating mild pain (Table 1) . Analgesics were prescribed to 86.3% of patients reporting pain, mainly paracetamol (63.2% of prescriptions) and dextropropoxyphene (25.3% of prescriptions).
One-month follow-up
Follow-up data were collected at a median of 34 days after surgery ( Table 2 ). Local complications that could be inXuenced by the use of Wbrin sealant were recorded in 4.7% of patients overall: 3.0% of patients had haematoma, 1.4% seroma and 0.3% (four patients) recurrence. No cases of neuralgia at the operating site were recorded; one infection was noted. The mean VAS-graded pain score at that time was 1.8. Only 2.1% of the patients scored pain >3 on the VAS (moderate or severe). No diVerences in pain intensity were evident between the three most used surgical techniques. The mean (SD) duration of sick leave was 25.2 (13.5) days and was comparable between active and sedentary workers.
Discussion
Initial studies with Tisseel ® Wbrin sealant as a method of mesh Wxation in tension-free hernia repair were promising, prompting further investigation of its utility in large, con- Tisseel ® was introduced to France in 1982 and began to be used in hernia repair from 2002, a time when French surgeons were performing over 87,000 hernia repair operations per year, and quickly became popular as an alternative means of mesh Wxation. In the absence of randomised controlled trial data, in 2003, it was decided to set up a registry to collect data on the use of Tisseel ® as a means of mesh Wxation in hernioplasty, in order to assess its feasibility. This led to the design of this large, multicentre, observational study, which concluded in 2005.
In our study of 1,201 patients, we noted the following low rates of complications at 34 days follow-up: 3.0% haematoma, 1.4% seroma, 0.3% short-term recurrence, with a mean VAS pain score of 1.8. There was one infection noted, and no cases of neuralgia at the site of operation.
Since the completion of our study, many studies that assess the use of Wbrin sealant in the most popular forms of inguinal hernia repair have been published (Table 3 ). For example, in an Italian randomised controlled trial, Lovisetto et al. [15] compared Wbrin sealant with staples as a means of mesh Wxation in 197 patients undergoing TAPP repair of inguinal or femoral hernia. At 12-month followup, the mean VAS pain score (the primary endpoint) was signiWcantly lower in the sealant group (19 vs. 26 mm; P < 0.05). One haematoma/seroma was noted in the staples group and one recurrence in the sealant group. In another Italian randomised controlled trial of TAPP hernioplasty, 600 patients received Wxation with one of three diVerent tack systems or Wbrin sealant [16] . After 1 month, no recurrences were observed in any group, but morbidity was generally lower with Tisseel ® , with more rapid return to work noted.
A French study by Topart et al. [17] focused on TEP repair: Wbrin sealant was used for mesh Wxation in 66 patients, compared with staple Wxation in 102 patients. Adequate mesh Wxation was achieved with a lower incidence of chronic post-operative pain with Wbrin sealant versus staples (4.5 vs. 11.8%, respectively). Lau [18] compared outcomes with Wbrin sealant and staple Wxation following simultaneous bilateral TEP in 93 patients, demonstrating a signiWcant reduction of analgesic consumption in the Wbrin sealant group. There was a small increase in the incidence of post-operative seroma, although this was not considered to be clinically signiWcant. Finally, Olmi et al. [19] performed intra-peritoneal onlay mesh (IPOM) Wxation with Wbrin sealant in 60 selected patients. After an average of 23.7-months follow-up, one patient experienced trocar-site haematoma, but no other complications were observed. Regarding the Lichtenstein technique, Canonico et al. [20] assessed the use of Wbrin sealant in 80 patients in an Italian study with 12 months follow-up. No complications were observed, and the use of Wbrin sealant was considered to be eVective for the prevention of local haemorrhagic complications after herniorrhaphy in patients with coagulation disorders [9] . A Spanish study by Hidalgo et al. [21] assessed mesh Wxation using Wbrin sealant compared with polypropylene sutures in 55 patients treated for bilateral hernia using the Lichtenstein technique. Fibrin sealant and sutures were used for contralateral hernias in each patient. Similar overall outcomes were reported in both inguinal regions, but there was less post-operative pain and less inXammatory reaction associated with Wbrin-Wxed hernia repairs. Once again, there were no recurrences after 1 year of follow-up.
The results of our observational study complement the Wndings of other studies comparing Wbrin sealant with standard mesh Wxation methods, and suggest that Wbrin sealant may yield fewer haematomas, seromas, recurrences and less post-operative pain than mechanical means of mesh Wxation. The surgeons in our study found the sealant to be easy to use and operation times appear similar to studies reporting on mechanical forms of mesh in both open and laparoscopic hernia repair Wxation [3] . In terms of cost, the price of 2 mL of Wbrin sealant (the most commonly used dosage) is similar to that of staples. Clearly, large controlled trials are needed to conWrm or disprove these promising indications and we eagerly await the results of the TIMELI trial.
In terms of study limitations, we achieved only 90% of the target patient population before the end of the 1-year recruitment period precluded further enrolment. However, a cohort of 1,201 patients still represents a very large sample.
Given the design of this study, some other limitations deserve mention. In particular, the short-term follow-up is a major shortcoming, and a comprehensive attempt to obtain 12-month follow-up data would have yielded worthwhile information. Perhaps one might have expected to see slightly higher recurrence rates at 12-months follow-up. It is also possible that some small seromas or haematomas may have arisen and resolved between the 2-and 34-day follow-up assessments. The absence of a pre-deWned classiWcation system for each complication may also be criticised, as might be the absence of standardised operating procedures, including precise methods for mesh Wxation. However, it is important to remember that this study was initiated to collect data reXecting the widespread use of Tisseel ® for hernia repair in day-to-day surgical practice in 2003-2004, in the absence of randomised control data. This is the Wrst study of its type in France and remains the largest of its kind in this country. Data from 42 institutions were collected, providing a robust and highly generalisable representation of Tisseel ® use in hernia surgery from across the nation.
Conclusion
With a total of 1,201 patients enrolled, this study is the only large-scale French study on the use of Wbrin sealant in hernia repair and provides epidemiological support for the use of Tisseel ® Wbrin sealant in the Wxation of prosthetic mesh during groin hernia repair. Fibrin sealant is an appropriate, atraumatic, easy-to-use alternative to the traditional, tissuepenetrating mesh Wxation devices used during common hernia repair techniques (Lichtenstein, totally extraperitoneal repair [TEP] and trans-abdominal pre-peritoneal patch repair [TAPP] ). In our study, the use of Tisseel ® was associated with a very low recurrence rate (0.3%), as well as a low rate of local complications (4.7% overall), and few patients experienced post-operative pain at 1-month followup, which has an important impact on the overall patient 
